6:17 PM
 | 
Apr 07, 2008
 |  BC Extra  |  Company News

Epix expands deal with CF Foundation

Epix (NASDAQ:EPIX) and Cystic Fibrosis Foundation Therapeutics, the foundation's drug discovery and development arm, expanded and extended until 2017 their 2005 deal for a CF research program. Epix will receive...

Read the full 138 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >